First Time Loading...

Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 72.55 USD -0.41% Market Closed
Updated: May 7, 2024

Wall Street
Price Targets

BSX Price Targets Summary
Boston Scientific Corp

Wall Street analysts forecast BSX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSX is 83.24 USD with a low forecast of 73.73 USD and a high forecast of 94.5 USD.

Lowest
Price Target
73.73 USD
2% Upside
Average
Price Target
83.24 USD
15% Upside
Highest
Price Target
94.5 USD
30% Upside

BSX Last Price Targets
Boston Scientific Corp

The latest public price target was made on Apr 25, 2024 by Richard Newitter from Truist Financial , who expects BSX stock to rise by 19% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Richard Newitter
Truist Financial
86 USD
Upside 19%
1 week ago
Apr 25, 2024
Boston Scientific (BSX) PT Raised to $86 at Truist Securities
StreetInsider
Vijay Kumar
Evercore ISI
78 USD
Upside 8%
1 week ago
Apr 25, 2024
Boston Scientific price target raised to $78 from $72 at Evercore ISI
TheFly
Shagun Singh
RBC Capital
82 USD
Upside 13%
1 week ago
Apr 25, 2024
Boston Scientific (BSX) PT Raised to $82 at RBC Capital
StreetInsider
Anthony Petrone
Mizuho Securities
85 USD
Upside 17%
1 week ago
Apr 25, 2024
Boston Scientific (BSX) PT Lowered to $85 at Mizuho
StreetInsider
David Rescott
Robert W. Baird
84 USD
Upside 16%
1 week ago
Apr 25, 2024
Boston Scientific (BSX) PT Raised to $84 at Baird
StreetInsider
Steven Lichtman
Oppenheimer
77 USD
Upside 6%
1 week ago
Apr 25, 2024
Boston Scientific (BSX) PT Raised to $77 at Oppenheimer
StreetInsider
Lawrence Biegelsen
Wells Fargo
82 USD
Upside 13%
1 week ago
Apr 25, 2024
Boston Scientific (BSX) PT Raised to $82 at Wells Fargo
StreetInsider
Marie Thibault
BTIG
80 USD
Upside 10%
1 week ago
Apr 24, 2024
Boston Scientific (BSX) PT Raised to $80 at BTIG
StreetInsider
Pito Chickering
Deutsche Bank
73 USD
Upside 1%
1 week ago
Apr 24, 2024
Boston Scientific price target raised to $73 from $63 at Deutsche Bank
TheFly
Rick Wise
Stifel Nicolaus
83 USD
Upside 14%
1 week ago
Apr 24, 2024
Boston Scientific (BSX) PT Raised to $83 at Stifel
StreetInsider
Marie Thibault
BTIG
74 USD
Upside 2%
3 weeks ago
Apr 15, 2024
Boston Scientific price target raised to $74 from $72 at BTIG
TheFly
John Eade
Argus Research
80 USD
Upside 10%
1 month ago
Apr 3, 2024
Boston Scientific (BSX) PT Raised to $80 at Argus
StreetInsider
Unknown Analyst
J.P. Morgan
55 USD
Downside 24%
1 year ago
Feb 2, 2023
JP Morgan Maintains Overweight on Boston Scientific, Raises Price Target to $55
Benzinga
Unknown Analyst
Needham
53 USD
Downside 27%
1 year ago
Feb 2, 2023
Needham Maintains Buy on Boston Scientific, Raises Price Target to $53
Benzinga
Show More Price Targets
Show Less Price Targets
Richard Newitter
Truist Financial
Price Target 86 USD
Upside/Downside 19%
View Source
Vijay Kumar
Evercore ISI
Price Target 78 USD
Upside/Downside 8%
View Source
Shagun Singh
RBC Capital
Price Target 82 USD
Upside/Downside 13%
View Source
Anthony Petrone
Mizuho Securities
Price Target 85 USD
Upside/Downside 17%
View Source
David Rescott
Robert W. Baird
Price Target 84 USD
Upside/Downside 16%
View Source
Steven Lichtman
Oppenheimer
Price Target 77 USD
Upside/Downside 6%
View Source
Lawrence Biegelsen
Wells Fargo
Price Target 82 USD
Upside/Downside 13%
View Source
Marie Thibault
BTIG
Price Target 80 USD
Upside/Downside 10%
View Source
Pito Chickering
Deutsche Bank
Price Target 73 USD
Upside/Downside 1%
View Source
Rick Wise
Stifel Nicolaus
Price Target 83 USD
Upside/Downside 14%
View Source
Marie Thibault
BTIG
Price Target 74 USD
Upside/Downside 2%
View Source
John Eade
Argus Research
Price Target 80 USD
Upside/Downside 10%
View Source
Unknown Analyst
J.P. Morgan
Price Target 55 USD
Upside/Downside 24%
View Source
Unknown Analyst
Needham
Price Target 53 USD
Upside/Downside 27%
View Source
Show More Price Targets
Show Less Price Targets
Boston Scientific Corp Competitors:
Price Targets
041830
InBody Co Ltd
33% Upside
SYK
Stryker Corp
17% Upside
78W
Modulight Oyj
119% Upside
ABT
Abbott Laboratories
22% Upside
SEZI
Senzime AB (publ)
77% Upside
228850
Rayence Co Ltd
55% Upside
688626
Xiangyu Medical Co Ltd
43% Upside
6Y1
Integrum AB
25% Upside

Revenue
Forecast

Revenue Estimate
Boston Scientific Corp

For the last 8 years the compound annual growth rate for Boston Scientific Corp's revenue is 8%. The projected CAGR for the next 3 years is 10%.

8%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Boston Scientific Corp

For the last 8 years the compound annual growth rate for Boston Scientific Corp's operating income is 13%. The projected CAGR for the next 3 years is 28%.

13%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-35%
Average Miss

Net Income
Forecast

Net Income Estimate
Boston Scientific Corp

The compound annual growth rate of Boston Scientific Corp's net income for the next 3 years is 40%.

N/A
Past Growth
40%
Estimated Growth
Estimates Accuracy
-59%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BSX's stock price target?
Price Target
83.24 USD

According to Wall Street analysts, the average 1-year price target for BSX is 83.24 USD with a low forecast of 73.73 USD and a high forecast of 94.5 USD.

What is Boston Scientific Corp's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Boston Scientific Corp's revenue is 8%. The projected CAGR for the next 3 years is 10%.

What is Boston Scientific Corp's Operating Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Boston Scientific Corp's operating income is 13%. The projected CAGR for the next 3 years is 28%.

What is Boston Scientific Corp's Net Income forecast?
Projected CAGR
40%

The compound annual growth rate of Boston Scientific Corp's net income for the next 3 years is 40%.